Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial …,

“Positive data from this important study would significantly advance MYMD-1’s potential to become a blockbuster drug for inflammation and aging.” MYMD …, “Positive data from this important study would significantly advance MYMD-1’s potential to become a blockbuster drug for inflammation and aging.” MYMD …, Read More

Scroll to Top